Health officials hope new Omicron vaccine will improve uptake of COVID-19 boosters – CTV

Oct. 8, 2022

OTTAWA – Health Canada approved on Friday the use of the Pfizer-BioNTech COVID-19 booster vaccine that targets the BA.4 and BA.5 strains of the Omicron variant.
The vaccine, which is approved for people at least 12 years old, can be given three to six months after a second dose of the primary vaccine series, or the most recent booster shot.

Health Canada said the bivalent booster has already been given to nearly five million people in the United States and there have been no new safety concerns.

“Canada will have enough supply of the Omicron-targeting bivalent vaccines to cover the anticipated demand for fall boosters,” Dr. Howard Njoo, Canada’s deputy chief public health officer, said on Thursday.

Njoo said people who already had a booster shot of the original mRNA vaccines do not need to get a bivalent booster.

Read more: https://www.ctvnews.ca/health/coronavirus/health-officials-hope-new-omicron-vaccine-will-improve-uptake-of-covid-19-boosters-1.6100427